Background Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease
worldwide and the leading cause of liver-related morbidity and mortality. We aimed to …

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The
estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among …

Non-alcoholic fatty liver disease (NAFLD) affects 20–25% of the general population and is
associated with morbidity, increased mortality, and elevated health-care costs. Most NAFLD …

Purpose of review To assess the current challenges regarding liver diseases, including the
burden of disease, access to care, screening, and treatment needs in Latin America. Recent …

Background Non-alcoholic fatty liver disease (NAFLD) was previously a neglected disease
that is now becoming a worldwide pandemic. A better understanding of its incidence and …

Phenolics can decrease the levels of advanced glycation end products (AGEs) from
proteins, but their mechanisms in complex mixtures are poorly understood. Leaf extracts and …

Non-alcoholic fatty liver disease (NAFLD) is reaching epidemic proportions worldwide.
Collectively, Latin American countries have some of the highest obesity rates in the world …

Background Diabetes has been increasing worldwide and is now among the 10 leading
causes of death globally. Diabetic kidney disease (DKD), a complication of poorly managed …

Diabetes mellitus (DM) is a group of metabolic disorders characterized by hyperglycemia,
insulin insufficiency or insulin resistance, and many issues, including vascular …

Type 2 diabetes is a global epidemic, and many people feel stigmatized for having this
disease. The stigma is a relevant barrier to diabetes management. However, evidence in …